Sinocare : Sinocare prevails in CGM trademark spat with Abbott

Sinocare announced recently that it successfully defended itself in court against trademark infringement claims brought by Abbott (NYSE:ABT). The China-based continuous glucose monitor (CGM) maker defended itself in the High Court of Justice (Chancery Division) of England and Wales against claims regarding trademark infringement and passing off. Abbott claimed that Sinocare's iCan i3 CGM system [...] The post Sinocare prevails in CGM trademark spat with Abbott appeared first on Drug Delivery Business.